GlucoTrack, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
GCTK Nasdaq 3840 glucotrack.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GlucoTrack, Inc.

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions - May 26th, 2026 6:00 am
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - May 14th, 2026 3:27 pm
Glucotrack Submits Blood Glucose Monitoring Technology to FDA - May 7th, 2026 1:50 pm
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology - May 7th, 2026 11:00 am
Glucotrack Shows Long-Term Accuracy of Implantable Glucose Monitor - Apr 30th, 2026 2:56 pm
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology - Apr 30th, 2026 7:00 am
Study Supports GlucoTrack’s Blood Glucose Monitoring Implant - Apr 21st, 2026 9:59 am
Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - Apr 21st, 2026 6:00 am
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - Mar 30th, 2026 2:50 pm
Glucotrack to File for FDA Exemption Based on 2025 Milestones - Mar 27th, 2026 7:59 pm
BC-Most Active Stocks - Mar 27th, 2026 8:30 am
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones - Mar 27th, 2026 6:01 am
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit - Mar 10th, 2026 6:01 am
Glucotrack Announces 3 New Patents to Monitor Blood Glucose - Jan 29th, 2026 3:42 pm
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - Jan 29th, 2026 6:01 am
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - Dec 30th, 2025 6:00 am
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - Nov 13th, 2025 2:05 pm
Glucotrack, Inc. Encourages Shareholders to Vote - Nov 3rd, 2025 2:05 pm
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - Oct 29th, 2025 2:05 pm
Glucotrack, Inc. Reminds Shareholders to Vote - Oct 28th, 2025 6:00 am